Benzyl L-leucyl-L-phenylalaninate (TFA), 98%, 250mg

2-Bromo-1,3-diethylbenzene, 95.0%, 1g

6-BENZYL-3-(3-(THIAZOL-5-YLMETHOXY)PHENYL)-3,4-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-2,7(1H,6H)-DIONE, 95%, 100mg

2-(Chloromethyl)pyridine Hydrochloride>97.0%(T)250g

2-Chloro-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one hydrochloride, 97%, 5g

2-Amino-4-iodobenzoic acid, 97.0%, 25g

(3R,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-3-carboxylic acid, 95.0%, 5g

Boc-a-methyl-DL-Valine, 97.0%, 1g

4-Methoxy-nicotinonitrile, 95.0%, 250mg

2-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(octyloxy)phenol, 98%, 500g

3,5-Dichloro-4-hydroxybenzonitrile, 97.0%, 25g

Colonne capillaire GC ROTI®Cap-1, 25 m, 0,32 mm, 0,25 µm, 1 pièce(s)

2-(2-Pyridyl)benzoxazole>97.0%(GC)(T)5g